PUBLICATION ORIENTED PROJECTS

[aravindabio]

PUBLICATION ORIENTED PROJECT

Dear,

 We are providing full time guidance forAcademic Projects, Research Projects and Publication Oriented Projects for Final Year Students (M.Sc/M.Tech/B.Tech/Pharmacy), Research Scholars and Faculties.

 

COURSE:As per the Student interested Topic or assigned by us

TIMINGS:Student convenience

Duration:45 Days

NOTE:Online and Weekend Projects are also availableon request. (Software will be provided.)

Topics of Projects:

1.    QSAR STUDIES:

v 2D QSAR

v 3D QSAR

2.    ADMET :

v ADME and Toxicity Predictions

3.    DOCKING :

v Novel Ligands

v Synthetic Ligands

v Natural Compound

v Comparative Docking (Various Targets)

v Comparative Docking (Various Ligands)

4.    MOLECULAR DOCKING & QSAR STUDIES:

v Molecular Docking and 3D QSAR for Published Ligands

v Published/ Designed: Comparative Analysis of Docking Studies

5.    HOMOLOGY MODELING & DOCKING STUDIES.

AravindaBiosolutions Pvt. Ltd. is a comprehensive training/projects providing organization in the areas of Bioinformatics, Cheminformatics, Molecular Modeling, Drug Designing and Clinical Research since last 8 years. The organization runs regular/short-term training programs and offer academic/research/Publication oriented projects in the areas of Bioinformatics, Cheminformatics, Molecular Modeling, Drug designing & Clinical Research. The courses and projects have been suitably designed keeping in view the type of demand in the industry. All the projects offered at the institute are original and is provided by our expert Faculties, Project consultants, Research Scholars.

 

PUBLICATION DETAILS OF OUR STUDENTS AND FACULTIES:

 

1.      MOLECULAR MODELING, DOCKING AND ADMET STUDIES TOWARDS DEVELOPMENT OF NOVEL DISOPYRAMIDE ANALOGS FOR POTENTIAL INHIBITION OF HUMAN VOLTAGE GATED SODIUM CHANNEL PROTEINS. KhunzaMeraj, Manoj Kumar Mahto, N Blessy Christina, Nidhi Desai, SajadShahbazi, Prof. M Bhaskar. Bioinformation. 2012, 8(23), 1139-1146.

 

2.      ADMET & MOLECULAR DOCKING STUDIES OF NOVEL ZANAMIVIR ANALOGS AS NEURAMINIDASE INHIBITORS. Manoj Kumar Mahto, V Likhitha Raj, Prof. M. Bhaskar, Divya.R. International Journal of Pharmaceutical Sciences Review and Research. 2012, 13(1), 91-94.

 

3.      DEVELOPMENT OF BETTER ANALOGS OF VALPROIC ACID FOR THE TREATMENT OF EPILEPSY BY CADD. Manoj Kumar Mahto, Jaya Tripathi, Divya. R, Prof. M. Bhaskar. International Journal of Pharmaceutical Sciences and Drug Research. 2012, 4(1), 77-79.

 

4.      INSILICO DESIGN AND DISCOVERY OF SOME NOVEL ACHE INHIBITORS FOR TREATMENT OF ALZHEIMER’S DISORDER.Sandeep Reddy Ch, Sree Kumar Reddy G, Manoj Kumar Mahto, PavanKunala, ChaitanyaKanth R. Research Journal of Pharmacy and Technology. 2012, 5 (3), 425-428.

 

5.      MOLECULAR DOCKING AND TOXICITY ANALYSIS OF NOVEL ATORVASTATIN STRUCTURAL ANALOGUES WITH HMG-COA REDUCTASE, Jaya Tripathi, Manoj Kumar Mahto, Divya. R, Prof. M. Bhaskar, SajadShahbazi. Asian Journal of Research in Chemistry. 2012, 5(3), 386-389.

 

6.      COMPARATIVE DOCKING STUDIES OF ESTROGEN RECEPTOR INHIBITORS AND THEIR BINDING INTERACTION ANALYSIS,Nidhi Desai, Manoj Kumar Mahto, B. Alekhya, C.R.Naveen, Prof. M.Bhaskar. International Journal of Pharmaceutical Sciences Review and Research. 2012, 16(1), 91-95.

 

7.      DOCKING ANALYSIS, ADME AND TOXICITY PROFILES OF INDAZOLE PYRIDINE BASED PROTEIN AKT INHIBITORS, N Blessy Christina, Manoj Kumar Mahto, KhunzaMeraj, Prof. M Bhaskar. International Journal of Pharmaceutical Sciences Review and Research.2012, 17(2), 56-61.

 

8.      MOLECULAR DOCKING AND ADMET STUDY OF QUINOLINE-BASED DERIVATIVES FOR ANTI-CANCER ACTIVITY, Manoj Kumar Mahto, KhunzaMeraj, Eftekhari K, Zeinab MN, Poojitha G, Bhaskar M. VRI Bioinformatics & Proteomics. 2013, 1(1), 1-8.

 

9.      PHARMACOPHORE MODELLING, 3D-QSAR STUDY AND DOCKING OF NAPHTHOL DERIVATIVES AS B-RAF(V600E) RECEPTOR ANTAGONISTS, KhunzaMeraj, K. Kiran Kumar, Mohamed Sidig, AzamSoltany, P. Anugnya Reddy, Manoj Kumar Mahto, M Bhaskar. VRI Bioinformatics & Proteomics.  2013, 1(1), 18-29.

 

10.  3D QSAR AND PHARMACOPHORE IDENTIFICATION OF ISOQUINOLINE AND BENZIMIDAZOLE ANALOGS AS POTENT C-RAF INHIBITORS. Blessy Christina N, Manoj Kumar Mahto, UdaykumarDasari, M Bhaskar. Int. J. Bioassays.2013, 02(10), 1327-1332.

 

11.  3-PHENYLQUINOLINYLCHALCONE DERIVATIVES: PHARMACOPHORE MODELLING, 3D-QSAR ANALYSIS AND DOCKING STUDIES AS ANTI-CANCER AGENTS.Manoj Kumar Mahto, SangeetaYadav, Sri ram Kalyan, SubarnaGanguli, MatchaBhaskar. Int. J. Bioassays. 2014, 3(2), 1756-1761.

 

12.  STRUCTURE BASED DRUG DESIGNING OF NEW ACETYLCHOLINESTERASE INHIBITORS FOR ALZHEIMER’S DISEASE .Preeth.M, Shobana.J, AsnetMary.J, Suresh.A, Suresh.V, SenthilKumar.N. J Biosci Tech, 2010; 1 (4), 162-169.

 

13.  IN SILICO DRUG DESIGNING AND DOCKING ANALYSIS FOR HYPERTENSION USING NIFEDIPINE AS A LEAD MOLECULE. P HarshaTeja.IJPRD, 2011; 3(4), 104-108.

 

14.  ANALOGS OF CARBIDOPA: INSILICO DESIGN & DEVELOPMENT OF NOVEL DOPA DECARBOXYLASE INHIBITORS IN THE TREATMENT OF PARKINSON’S DISEASE. M Lakshmi Vasavi Devi, Deepak Reddy Gade, T GopiRaju, PavanKunala. Journal of Pharmaceutical Sciences & Research. 2011, 3(4), 1176-1181.

 

 

 

 

CONTACT US:

Manoj Kumar,

 Bioinformatics Sr. Research Faculty,
ARAVINDA BIOSOLUTIONS PVT. LTD.

Hyderabad- 44, AP, INDIA
PH: 040-66628773, 66628774.

Email: manoj...@aravindabio.com
URL:-http://www.aravindabio.com